tiprankstipranks
Advertisement
Advertisement

EchoIQ Director Increases Indirect Shareholding via Performance Rights Conversion

Story Highlights
  • EchoIQ director Steve Formica converted vested performance rights into 625,000 new ordinary shares, boosting his indirect equity stake.
  • The transaction reduces Formica’s performance rights balance and shifts his exposure toward ordinary shares, aligning interests with shareholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EchoIQ Director Increases Indirect Shareholding via Performance Rights Conversion

Claim 30% Off TipRanks

EchoIQ Limited ( (AU:EIQ) ) has shared an announcement.

EchoIQ Limited has disclosed a change in director Steve Formica’s indirect holdings, following the vesting and exercise of a tranche of performance rights linked to the company’s share price. Through related party investment entities, Formica converted 625,000 Class H performance rights into fully paid ordinary shares after the rights vested upon meeting a 20-day volume-weighted average price hurdle.

As a result of this transaction, Formica’s indirect interest increased to 29.6 million ordinary shares while his remaining performance rights decreased accordingly, with no cash consideration involved. The move slightly shifts the mix of his equity exposure from contingent incentives to ordinary equity, modestly aligning his interests more directly with long-term shareholders and signaling confidence associated with the company’s recent share-price performance.

The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.90 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.

More about EchoIQ Limited

EchoIQ Limited operates in the medical technology sector, focusing on advanced analytics for cardiac imaging and related diagnostic support tools. The company develops and deploys software-driven solutions designed to assist clinicians in identifying and managing heart conditions, targeting healthcare providers and institutions seeking to enhance cardiac care accuracy and efficiency.

Average Trading Volume: 3,227,255

Technical Sentiment Signal: Buy

Current Market Cap: A$593.3M

Learn more about EIQ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1